Eye study underscores the long-lasting benefits of controlling diabetes

People with type 2 diabetes who intensively controlled their blood sugar level during the landmark ACCORD Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy.